Soleno Therapeutics Statistics
Total Valuation
SLNO has a market cap or net worth of $3.64 billion. The enterprise value is $3.39 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLNO has 53.15 million shares outstanding. The number of shares has increased by 50.95% in one year.
| Current Share Class | 53.15M |
| Shares Outstanding | 53.15M |
| Shares Change (YoY) | +50.95% |
| Shares Change (QoQ) | +9.32% |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 102.61% |
| Float | 44.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 52.75 |
| PS Ratio | 95.60 |
| Forward PS | 12.96 |
| PB Ratio | 14.37 |
| P/TBV Ratio | 15.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 103.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.13, with a Debt / Equity ratio of 0.22.
| Current Ratio | 15.13 |
| Quick Ratio | 14.87 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -62.78 |
Financial Efficiency
Return on equity (ROE) is -69.53% and return on invested capital (ROIC) is -40.58%.
| Return on Equity (ROE) | -69.53% |
| Return on Assets (ROA) | -36.60% |
| Return on Invested Capital (ROIC) | -40.58% |
| Return on Capital Employed (ROCE) | -59.84% |
| Revenue Per Employee | $354,967 |
| Profits Per Employee | -$1.97M |
| Employee Count | 92 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.50% in the last 52 weeks. The beta is -2.56, so SLNO's price volatility has been lower than the market average.
| Beta (5Y) | -2.56 |
| 52-Week Price Change | +39.50% |
| 50-Day Moving Average | 80.96 |
| 200-Day Moving Average | 63.84 |
| Relative Strength Index (RSI) | 36.69 |
| Average Volume (20 Days) | 1,637,125 |
Short Selling Information
The latest short interest is 6.31 million, so 11.87% of the outstanding shares have been sold short.
| Short Interest | 6.31M |
| Short Previous Month | 6.04M |
| Short % of Shares Out | 11.87% |
| Short % of Float | 14.06% |
| Short Ratio (days to cover) | 4.15 |
Income Statement
In the last 12 months, SLNO had revenue of $32.66 million and -$181.08 million in losses. Loss per share was -$3.97.
| Revenue | 32.66M |
| Gross Profit | 31.96M |
| Operating Income | -186.32M |
| Pretax Income | -65.41M |
| Net Income | -181.08M |
| EBITDA | -184.32M |
| EBIT | -186.32M |
| Loss Per Share | -$3.97 |
Full Income StatementBalance Sheet
The company has $286.84 million in cash and $52.77 million in debt, giving a net cash position of $241.07 million or $4.54 per share.
| Cash & Cash Equivalents | 286.84M |
| Total Debt | 52.77M |
| Net Cash | 241.07M |
| Net Cash Per Share | $4.54 |
| Equity (Book Value) | 240.14M |
| Book Value Per Share | 4.76 |
| Working Capital | 295.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$84.28 million and capital expenditures -$213,000, giving a free cash flow of -$84.49 million.
| Operating Cash Flow | -84.28M |
| Capital Expenditures | -213,000 |
| Free Cash Flow | -84.49M |
| FCF Per Share | -$1.59 |
Full Cash Flow StatementMargins
| Gross Margin | 97.87% |
| Operating Margin | -570.55% |
| Pretax Margin | -554.49% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLNO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -50.95% |
| Shareholder Yield | -50.95% |
| Earnings Yield | -4.98% |
| FCF Yield | -2.32% |
Analyst Forecast
The average price target for SLNO is $112.50, which is 64.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $112.50 |
| Price Target Difference | 64.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 26, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
SLNO has an Altman Z-Score of 13.13 and a Piotroski F-Score of 1.
| Altman Z-Score | 13.13 |
| Piotroski F-Score | 1 |
